Back to search

Article

NK cells contribute to resistance to anti-PD1 therapy in immune-excluded melanomas

2023-12-14

Abstract excerpt

Immune checkpoint blockade (ICB) has become a standard of care in the treatment of metastatic melanoma (MM). Although ICB is particularly successful in some MM patients, more than half do not obtain a durable benefit. Biomarkers that predict response are urgently needed and overcoming intrinsic resistance is key to improving the success of ICB therapy. Using single cell RNA sequencing, we characterized the immune...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1bbbaef7-0990-5a63-912d-4c356796be0a
DOI
10.1101/2023.12.14.571631
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NK cells contribute to resistance to anti-PD1 therapy in immune-excluded melanomasDOI 10.1101/2023.12.14.571631
Select a neighboring publication to make it the new centre.